REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad De Laboratorio Unilab Limitada (Colombia)

Main Activities: Diagnostic Imaging Centers
Secondary Activities: Management of Companies and Enterprises | Ambulatory Health Care Services | Other Ambulatory Health Care Services
Full name: Unidad De Laboratorio Unilab Limitada Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Unidad De Laboratorio Unilab Limitada is a company in Colombia, with a head office in Barranquilla. The company operates in the Diagnostic Imaging Centers sector. The company was established on August 29, 1996. From the latest financial highlights, Unidad De Laboratorio Unilab Limitada reported a net sales revenue increase of 229.35% in 2025. Its’ total assets recorded a growth of 181.96%. The net profit margin of Unidad De Laboratorio Unilab Limitada decreased by 4.03% in 2025.

Headquarters
Cl 59 No 50 - 17
Barranquilla; Atlantico;

Contact Details: Purchase the Unidad De Laboratorio Unilab Limitada report to view the information.

Basic Information
Registered Capital:
Purchase the Unidad De Laboratorio Unilab Limitada report to view the information.
Financial Auditors:
Purchase the Unidad De Laboratorio Unilab Limitada report to view the information.
Incorporation Date:
August 29, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad De Laboratorio Unilab Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
229.35%
Total Operating Revenue
229.35%
Operating Profit
185.12%
EBITDA
343.99%
Net Profit/Loss for the Period
187.76%
Total Assets
181.96%
Total Equity
149.74%
Operating Profit Margin
-4.52%
Net Profit Margin
-4.03%
Return on Equity (ROE)
12.14%
Quick Ratio
-1.09%
Cash Ratio
-0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?